Palvella Therapeutics (PVLA) FCF Margin Growth (1y) (2015 - 2024)
Palvella Therapeutics (PVLA) FCF Margin Growth (1y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -152,979.00 |
| Dec 31, 2023 | 944,666.00 |
| Sep 30, 2023 | 296,960.00 |
| Jun 30, 2023 | 697,922.00 |
| Mar 31, 2023 | -33,984.00 |
| Dec 31, 2022 | -1.00 Mn |
| Sep 30, 2022 | -265,413.00 |
| Jun 30, 2022 | -1.10 Mn |
| Mar 31, 2022 | -11,603.00 |
| Dec 31, 2021 | -52,957.00 |
| Sep 30, 2021 | -10,458.00 |
| Jun 30, 2021 | 408,266.00 |
| Mar 31, 2021 | 3,505.00 |
| Dec 31, 2020 | 48,362.00 |
| Sep 30, 2020 | -17,591.00 |
| Jun 30, 2020 | 11,962.00 |
| Mar 31, 2020 | 4,959.00 |
| Dec 31, 2019 | 151,611.00 |
| Sep 30, 2019 | 9,082.00 |
| Jun 30, 2019 | -13,854.00 |